Neoadjuvant Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer

被引：0
|
作者：
Kovtun, K. [1 ,2 ]
Moser, J. A. [1 ]
Callery, M. [1 ]
Kent, T. [1 ]
Tseng, J. [1 ]
Miksad, R. [1 ]
Bullock, A. [1 ]
Schlechter, B. [1 ]
Mahadevan, A. [1 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Harvard Radiat Oncol Program, Boston, MA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2016.06.1090
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2486
引用
收藏
页码：E198 / E198
页数：1
相关论文
共 50 条
  • [21] Prognostic Factors for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer Receiving Neoadjuvant FOLFIRINOX
    Choi, Young Hoon
    Lee, Sang Hyub
    You, Min Su
    Shin, Bang Sup
    Paik, Woo Hyun
    Ryu, Ji Kon
    Kim, Yong-Tae
    Kwon, Wooil
    Jang, Jin-Young
    Kim, Sun-Whe
    GUT AND LIVER, 2021, 15 (02) : 315 - 323
  • [22] Neoadjuvant FOLFIRINOX for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis
    Choi, Jin G.
    Nipp, Ryan D.
    Tramontano, Angela
    Ali, Ayman
    Zhan, Tiannan
    Pandharipande, Pari
    Dowling, Emily C.
    Ferrone, Cristina R.
    Hong, Theodore S.
    Schrag, Deborah
    Fernandez-Del Castillo, Carlos
    Ryan, David P.
    Kong, Chung Yin
    Hur, Chin
    ONCOLOGIST, 2019, 24 (07): : 945 - 954
  • [23] PROGNOSTIC FACTORS FOR PATIENTS WITH BORDERLINE RESECTABLE OR LOCALLY ADVANCED PANCREATIC CANCER RECEIVING NEOADJUVANT FOLFIRINOX
    Choi, Young Hoon
    Lee, Sang Hyub
    You, Min Su
    Paik, Woo Hyun
    Ryu, Ji Kon
    Kim, Yong-Tae
    GASTROENTEROLOGY, 2019, 156 (06) : S321 - S322
  • [24] Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer
    Ferrone, Cristina R.
    Marchegiani, Giovanni
    Hong, Theodore S.
    Ryan, David P.
    Deshpande, Vikram
    McDonnell, Erin I.
    Sabbatino, Francesco
    Santos, Daniela Dias
    Allen, Jill N.
    Blaszkowsky, Lawrence S.
    Clark, Jeffrey W.
    Faris, Jason E.
    Goyal, Lipika
    Kwak, Eunice L.
    Murphy, Janet E.
    Ting, David T.
    Wo, Jennifer Y.
    Zhu, Andrew X.
    Warshaw, Andrew L.
    Lillemoe, Keith D.
    Fernandez-del Castillo, Carlos
    ANNALS OF SURGERY, 2015, 261 (01) : 12 - 17
  • [25] ASO Visual Abstract: Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
    Alva-Ruiz, Roberto
    Yohanathan, Lavanya
    Yonkus, Jennifer A.
    Abdelrahman, Amro M.
    Gregory, Lindsey A.
    Halfdanarson, Thorvadur R.
    Mahipal, Amit
    McWilliams, Robert R.
    Ma, Wen Wee
    Hallemeier, Christopher L.
    Graham, Rondell P.
    Grotz, Travis E.
    Smoot, Rory L.
    Cleary, Sean P.
    Nagorney, David M.
    Kendrick, Michael L.
    Truty, Mark J.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (03) : 1594 - 1595
  • [26] Pathologic Outcomes in Borderline Resectable and Locally Advanced Pancreatic Cancer Patients Receiving Neoadjuvant Stereotactic Body Radiation Therapy
    Rosati, L. M.
    He, J.
    Moningi, S.
    Hacker-Prietz, A.
    Huebner, T. A.
    Assadi, R. K.
    Laheru, D. A.
    Zheng, L.
    De Jesus-Acosta, A.
    Le, D. T.
    Fishman, E. K.
    Hruban, R. H.
    Hirose, K.
    Makary, M. A.
    Cameron, J. L.
    Pawlik, T. M.
    Wolfgang, C. L.
    Weiss, M. J.
    Ellsworth, S. G.
    Herman, J. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E127 - E128
  • [27] RESECTION RATE AND SURVIVAL AFTER NEOADJUVANT THERAPY FOR BORDERLINE RESECTABLE AND LOCALLY ADVANCED PANCREATIC CANCER: A PROSPECTIVE COHORT STUDY
    Serafini, Simone
    Moletta, Lucia
    Pierobon, Elisa Sefora
    Ponzoni, Alberto
    Capovilla, Giovanni
    Piangerelli, Alfredo
    Valmasoni, Michele
    Sperti, Cosimo
    GASTROENTEROLOGY, 2020, 158 (06) : S1552 - S1552
  • [28] OPTIMAL ADJUVANT THERAPY IN PATIENTS WITH BORDERLINE RESECTABLE AND LOCALLY ADVANCED PANCREATIC CANCER WHO HAD RECEIVED NEOADJUVANT FOLFIRINOX
    Choi, Jin Ho
    Kim, Min Kyu
    Lee, Sang Hyub
    Park, Namyoung
    Kim, Jung
    Cho, In Rae
    Ryu, Ji Kon
    Kim, Yong-Tae
    Paik, Woo Hyun
    GASTROENTEROLOGY, 2022, 162 (07) : S741 - S741
  • [29] Proper adjuvant therapy in patients with borderline resectable and locally advanced pancreatic cancer who had received neoadjuvant FOLFIRINOX
    Choi, Jin Ho
    Kim, Min Kyu
    Lee, Sang Hyub
    Park, Jin Woo
    Park, Namyoung
    Cho, In Rae
    Ryu, Ji Kon
    Kim, Yong-Tae
    Jang, Jin-Young
    Kwon, Wooil
    Kim, Hongbeom
    Paik, Woo Hyun
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [30] Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy
    Addeo, Pietro
    Rosso, Edoardo
    Fuchshuber, Pascal
    Oussoultzoglou, Elie
    De Blasi, Vito
    Simone, Gael
    Belletier, Christine
    Dufour, Patrick
    Bachellier, Philippe
    ONCOLOGY, 2015, 89 (01) : 37 - 46
12345